Alpha Pro Tech Ltd Revenue Growth Rates (APT), Current and Historic Growth - CSIMarket
CSIMarket
 


Alpha Pro Tech Ltd   (NYSEAMER: APT)
 

APT's Revenue Growth by Quarter and Year

Alpha Pro Tech Ltd 's Revenue results by quarter and year




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/APT/growth
https://api.csimarket.com/api/v1/companies/APT/fundamentals
https://api.csimarket.com/api/v1/companies/APT/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
APT Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 16.60
2nd Quarter June 18.67
1st Quarter March 14.52
FY 49.79

APTs Annual Revenue
Alpha Pro Tech Ltd 's Revenue in the fiscal year 2025 $ 58.54 millions
Alpha Pro Tech Ltd 's Revenue in the fiscal year 2024 $ 56.93 millions
Alpha Pro Tech Ltd 's Revenue in the fiscal year 2023 $ 60.83 millions
Alpha Pro Tech Ltd 's Revenue in the fiscal year 2022 $ 61.98 millions
Alpha Pro Tech Ltd 's Revenue in the fiscal year 2021 $ 68.64 millions




APT Revenue third quarter 2026 Y/Y Growth Comment
Alpha Pro Tech Ltd achieved in the third quarter 2026, above Company average Revenue increase of 19.71% year on year, to $ 16.60 millions.

Looking into third quarter 2026 results within Medical Equipment & Supplies industry 69 other companies have achieved higher Revenue growth. While Alpha Pro Tech Ltd ' s Revenue growth of 19.71% ranks overall at the positon no. 1258 in the third quarter 2026.




APT Revenue ( Y/Y Growth %) 2026
FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 19.71 %
2nd Quarter June 15.75 %
1st Quarter March 8.44 %
FY   -

Financial Statements
Alpha Pro Tech Ltd 's third quarter 2026 Revenue $ 16.60 millions APT's Income Statement
Alpha Pro Tech Ltd 's third quarter 2025 Revenue $ 13.87 millions Quarterly APT's Income Statement


APT Revenue (Quarter on Quarter Growth %)

2026
FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -11.07 %
2nd Quarter June 28.58 %
1st Quarter March -4.16 %
FY (Year on Year)   -




Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #70
Healthcare Sector #226
Overall #1258

Revenue Y/Y Growth Statistics
High Average Low
165.77 % 7.29 % -54.53 %
(Dec 31 2020)   (Mar 31 2022)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #70
Healthcare Sector #226
Overall #1258
Revenue Y/Y Growth Statistics
High Average Low
165.77 % 7.29 % -54.53 %
(Dec 31 2020)   (Mar 31 2022)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Alpha Pro Tech Ltd 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
66.26 % 0.78 % -100 %
(Mar 31 2020)  


APT's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Alpha Pro Tech Ltd disclosed drop in Revenue from the second quarter by -11.07% to $ 16.60 millions, from $ 18.67 millions achived in the previous reporting period.

But that's not important problem, as Alpha Pro Tech Ltd 's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 20 other companies have achieved higher Revenue quarter on quarter growth. While Alpha Pro Tech Ltd 's Revenue growth quarter on quarter, overall rank is 384.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #21
Healthcare Sector #84
Overall #384
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #21
Healthcare Sector #84
Overall #384
Revenue Q/Q Growth Statistics
High Average Low
66.26 % 0.78 % -100 %
(Mar 31 2020)  


APT's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Alpha Pro Tech Ltd disclosed drop in Revenue from the second quarter by -11.07% to $ 16.60 millions, from $ 18.67 millions achived in the previous reporting period.

But that's not important problem, as Alpha Pro Tech Ltd 's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 20 other companies have achieved higher Revenue quarter on quarter growth. While Alpha Pro Tech Ltd 's Revenue growth quarter on quarter, overall rank is 384.


Alpha Pro Tech Ltd 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)
12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 64.94
Y / Y Revenue Growth (TTM) 12.78 %
Year on Year Revenue Growth Overall Ranking # 3011
Seqeuential Revenue Change (TTM) 4.4 %
Seq. Revenue Growth (TTM) Overall Ranking # 2590


Cumulative Revenue growth Comment
Alpha Pro Tech Ltd saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 12.78% year on year, to $ 65 millions if the fiscal year would have ended in Sep 30 2026.
Alpha Pro Tech Ltd 's trailing twelve months Revenue growth was higher than company's average 5.8% and higher than 8.75% growth in Jun 30 2026.
But from twelve months ended Jun 30 2026 rise was beneth at 4.4 % from $62.2 millions achieved in the period from Jun 30 2026 to Sep 30 2025.
We witness drop-off happening, more obvious observing the When you usual Q/Q TTM historic rise that is stronger at5.8%.

In the Healthcare sector 413 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2487 to 3011.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 138
Healthcare Sector # 414
Overall # 3011

Revenue TTM Y/Y Growth Statistics
High Average Low
120.08 %
5.8 %
-41.38 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 138
Sector # 373
S&P 500 # 2590
Cumulative Revenue growth Comment
Alpha Pro Tech Ltd saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 12.78% year on year, to $ 65 millions if the fiscal year would have ended in Sep 30 2026.
Alpha Pro Tech Ltd 's trailing twelve months Revenue growth was higher than company's average 5.8% and higher than 8.75% growth in Jun 30 2026.
But from twelve months ended Jun 30 2026 rise was beneth at 4.4 % from $62.2 millions achieved in the period from Jun 30 2026 to Sep 30 2025.
We witness drop-off happening, more obvious observing the When you usual Q/Q TTM historic rise that is stronger at5.8%.
The momentum is even more impressive from twelve months ended Jun 30 2026 exhibited at 4.4 % increase from $62.2 millions in the period from Jun 30 2026 to Sep 30 2025.

In the Healthcare sector 413 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2487 to 3011.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 138
Healthcare Sector # 414
Overall # 3011

Revenue TTM Y/Y Growth Statistics
High Average Low
120.08 %
5.8 %
-41.38 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 138
Sector # 373
S&P 500 # 2590




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
APT's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Natera Inc 34.08%$ 34.077 millions
Establishment Labs Holdings Inc 34.08%$ 34.075 millions
Beone Medicines Ltd 33.86%$ 33.861 millions
Ceribell Inc 33.72%$ 33.721 millions
Zomedica Corp 33.12%$ 33.123 millions
Intuitive Surgical Inc 32.71%$ 32.714 millions
Adc Therapeutics Sa32.20%$ 32.197 millions
Biomarin Pharmaceutical Inc32.02%$ 32.019 millions
The Pennant Group Inc 31.96%$ 31.965 millions
Beta Bionics Inc 30.92%$ 30.923 millions
Cadre Holdings inc 30.36%$ 30.362 millions
Krystal Biotech Inc 30.21%$ 30.206 millions
Sight Sciences Inc 29.83%$ 29.828 millions
Ge Healthcare Technologies Inc 29.41%$ 29.413 millions
Moderna Inc 29.23%$ 29.232 millions
Sonoma Pharmaceuticals Inc 28.02%$ 28.016 millions
Ani Pharmaceuticals Inc27.64%$ 27.638 millions
Geron Corporation27.45%$ 27.448 millions
Vericel Corporation26.47%$ 26.470 millions
Axogen inc 26.22%$ 26.218 millions
Cardio Diagnostics Holdings Inc 25.74%$ 25.744 millions
Edap Tms Sa25.55%$ 25.549 millions
Lifestance Health Group Inc 25.30%$ 25.303 millions
Rockwell Medical inc 25.21%$ 25.210 millions
Intelligent Bio Solutions Inc 25.19%$ 25.188 millions
The Oncology Institute Inc 24.31%$ 24.313 millions
Vanda Pharmaceuticals Inc 24.10%$ 24.098 millions
Mannkind Corporation24.04%$ 24.035 millions
Castle Biosciences Inc 23.90%$ 23.901 millions
Coherus Oncology inc 23.36%$ 23.360 millions


About Alpha Pro Tech Ltd Revenue Growth Rates (APT), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Alpha Pro Tech Ltd (CIK 884269).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001437749-26-036029
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Alpha Pro Tech Ltd’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.